Published in Clin Diagn Lab Immunol on November 01, 2001
Laboratory diagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol (2002) 3.21
Diagnosis of visceral leishmaniasis. Trans R Soc Trop Med Hyg (2010) 1.93
Rapid, noninvasive diagnosis of visceral leishmaniasis in India: comparison of two immunochromatographic strip tests for detection of anti-K39 antibody. J Clin Microbiol (2006) 1.75
Rapid detection of Leishmania infantum infection in dogs: comparative study using an immunochromatographic dipstick test, enzyme-linked immunosorbent assay, and PCR. J Clin Microbiol (2002) 1.40
Asymptomatic Leishmania infantum infection in an area of northwestern Italy (Piedmont region) where such infections are traditionally nonendemic. J Clin Microbiol (2009) 1.20
Parasite detection in patients with post kala-azar dermal leishmaniasis in India: a comparison between molecular and immunological methods. J Clin Pathol (2003) 1.11
Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol (2005) 1.09
The development and clinical evaluation of second-generation leishmaniasis vaccines. Vaccine (2011) 1.03
Diagnosis of visceral leishmaniasis in Bihar India: comparison of the rK39 rapid diagnostic test on whole blood versus serum. PLoS Negl Trop Dis (2013) 1.02
Diagnosis of mediterranean visceral leishmaniasis by detection of leishmania antibodies and leishmania DNA in oral fluid samples collected using an Oracol device. J Clin Microbiol (2011) 0.98
Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent - A Systematic Literature Review. PLoS Negl Trop Dis (2016) 0.89
Application of an improved method for the recombinant k 39 enzyme-linked immunosorbent assay to detect visceral leishmaniasis disease and infection in Bangladesh. Clin Diagn Lab Immunol (2005) 0.88
Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis. J Clin Microbiol (2005) 0.87
Two-dimensional difference gel electrophoresis (DIGE) analysis of sera from visceral leishmaniasis patients. Clin Proteomics (2011) 0.85
Evaluation of rk39 immunochromatographic test with urine for diagnosis of visceral leishmaniasis. Trans R Soc Trop Med Hyg (2011) 0.82
Developments in diagnosis and antileishmanial drugs. Interdiscip Perspect Infect Dis (2012) 0.81
Performance of rK39 immunochromatography and freeze-dried direct agglutination tests in the diagnosis of imported visceral leishmaniasis. Parasitol Res (2011) 0.80
Immunoblot analysis of the humoral immune response to Leishmania donovani polypeptides in cases of human visceral leishmaniasis: its usefulness in prognosis. Clin Diagn Lab Immunol (2002) 0.80
Rapid Tests and the Diagnosis of Visceral Leishmaniasis and Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Coinfection. Am J Trop Med Hyg (2015) 0.79
Detection of anti-leishmania (Leishmania) chagasi immunoglobulin G by flow cytometry for cure assessment following chemotherapeutic treatment of American visceral leishmaniasis. Clin Vaccine Immunol (2007) 0.78
Leishmaniasis revisited: Current aspects on epidemiology, diagnosis and treatment. J Transl Int Med (2015) 0.76
Application of Recombinant Proteins for Serodiagnosis of Visceral Leishmaniasis in Humans and Dogs. Iran Biomed J (2016) 0.75
Evaluation of an enzyme-linked immunosorbent assay based on crude Leishmania histone proteins for serodiagnosis of human infantile visceral leishmaniasis. Clin Vaccine Immunol (2012) 0.75
Field Adaptable Tests for Kala-Azar. Med J Armed Forces India (2011) 0.75
Bone marrow negative visceral leishmaniasis in an adolescent male. Iran J Parasitol (2013) 0.75
Systematic review of biomarkers to monitor therapeutic response in leishmaniasis. Antimicrob Agents Chemother (2014) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Rapid accurate field diagnosis of Indian visceral leishmaniasis. Lancet (1998) 3.55
Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc Natl Acad Sci U S A (1993) 3.40
rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis. J Infect Dis (1996) 2.93
New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis (1986) 2.92
An analysis of T cell responsiveness in Indian kala-azar. J Immunol (1987) 2.56
Diagnostic and prognostic value of K39 recombinant antigen in Indian leishmaniasis. J Parasitol (1995) 2.37
Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis. Infect Immun (1983) 1.97
Use of the leishmanin skin test and western blot analysis for epidemiological studies in visceral leishmaniasis areas: experience in a highly endemic focus in Alpes-Maritimes (France). Trans R Soc Trop Med Hyg (1995) 1.39
Serological investigations on Indian kala-azar. Clin Exp Immunol (1980) 1.36
Serodiagnosis of Asian leishmaniasis with a recombinant antigen from the repetitive domain of a Leishmania kinesin. Trans R Soc Trop Med Hyg (1995) 1.27
Leishmania in the Old World: 4. The distribution of L. donovani sensu lato zymodemes. Trans R Soc Trop Med Hyg (1986) 1.20
Prevalence and disease spectrum in a new focus of visceral leishmaniasis in Kenya. Trans R Soc Trop Med Hyg (1982) 1.20
Studies on the immunology and serology of leishmaniasis. IX. Serological investigation of the parasites of Indian kala-azar and Indian post-kala-azar dermal leishmaniasis. Trans R Soc Trop Med Hyg (1973) 1.16
Antigenic cross-reactivity between Mycobacterium bovis (BCG) and Leishmania donovani. Infect Immun (1977) 1.14
Evaluation of the direct agglutination test as an immunodiagnostic tool for kala-azar in India. Trans R Soc Trop Med Hyg (1993) 1.12
Enzyme-linked immunosorbent assay in the diagnosis of kala-azar in Bhadohi (Varanasi), India. Trans R Soc Trop Med Hyg (1991) 1.10
Reduction in the number of UCHL-1+ cells and IL-2 production in the peripheral blood of patients with visceral leishmaniasis. J Immunol (1991) 1.09
Western blot analysis of humoral immune response to Leishmania donovani antigens in patients with post-kala-azar dermal leishmaniasis. Trans R Soc Trop Med Hyg (1999) 1.04
An indirect fluorescent antibody (IFA) test for the serodiagnosis of Kala-Azar. J Commun Dis (1992) 0.96
Evaluation of enzyme-linked immunosorbent assay in the diagnosis of kala-azar in Malda district (West Bengal). Indian J Med Res (1993) 0.88
Rapid latex agglutination test for extraluminal amoebiasis. J Clin Pathol (1994) 0.84
Evidence of Leishmania donovani infection in household members residing with visceral leishmaniasis patients. J Commun Dis (1992) 0.81
Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N Engl J Med (1999) 5.02
Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. J Infect Dis (1999) 2.92
Study on clinico-epidemiological profile of HIV patients in eastern India. J Assoc Physicians India (2006) 2.87
Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, India. Trop Med Int Health (2006) 2.69
Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent. Trans R Soc Trop Med Hyg (2007) 2.53
The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India. Trop Med Int Health (2009) 2.35
Visceral leishmaniasis (kala-azar): challenges ahead. Indian J Med Res (2006) 1.86
Meeting the challenge of developing and maintaining radical hysterectomy skills. BJOG (2010) 1.71
Diagnostic PCR with Leishmania donovani specificity using sequences from the variable region of kinetoplast minicircle DNA. Trop Med Int Health (1999) 1.58
Platinum-based chemotherapy in metastatic breast cancer: current status. Cancer Treat Rev (2004) 1.56
Immunochromatographic strip-test detection of anti-K39 antibody in Indian visceral leishmaniasis. Ann Trop Med Parasitol (2002) 1.54
Splenic cytokine responses in Indian kala-azar before and after treatment. J Infect Dis (1998) 1.49
Anti-inflammatory studies on Euphorbia prostrata. J Ethnopharmacol (1989) 1.41
Down's syndrome with acute myeloid leukemia. J Assoc Physicians India (1994) 1.39
Inferior venacaval obstruction following burns. J Assoc Physicians India (1990) 1.39
Evaluation of PCR for diagnosis of Indian kala-azar and assessment of cure. J Clin Microbiol (2005) 1.38
Kala-azar epidemic in Varanasi district, India. Bull World Health Organ (1999) 1.36
Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006. Br J Cancer (2011) 1.33
Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India. J Antimicrob Chemother (1999) 1.28
Management of visceral leishmaniasis in rural primary health care services in Bihar, India. Trop Med Int Health (2010) 1.25
Increased levels of thiols protect antimony unresponsive Leishmania donovani field isolates against reactive oxygen species generated by trivalent antimony. Parasitology (2007) 1.23
First- and second-line drug resistance patterns among previously treated tuberculosis patients in India. Int J Tuberc Lung Dis (2010) 1.22
Genetics and visceral leishmaniasis: of mice and man. Parasite Immunol (2009) 1.21
Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis. Clin Diagn Lab Immunol (1997) 1.17
Resistance to treatment in Kala-azar: speciation of isolates from northeast India. Am J Trop Med Hyg (2001) 1.17
The in vivo susceptibility of Leishmania donovani to sodium stibogluconate is drug specific and can be reversed by inhibiting glutathione biosynthesis. Antimicrob Agents Chemother (2003) 1.13
Detection of campylobacter in gastroenteritis: comparison of direct PCR assay of faecal samples with selective culture. Epidemiol Infect (1998) 1.13
Evaluation of the direct agglutination test as an immunodiagnostic tool for kala-azar in India. Trans R Soc Trop Med Hyg (1993) 1.12
Risk factors for visceral leishmaniasis in India: further evidence on the role of domestic animals. Trop Med Int Health (2010) 1.10
Immunostimulatory cellular responses of cured Leishmania-infected patients and hamsters against the integral membrane proteins and non-membranous soluble proteins of a recent clinical isolate of Leishmania donovani. Clin Exp Immunol (2005) 1.08
Orofacial granulomatosis--a diagnostic enigma. Oral Dis (2013) 1.08
Influence of amorphous cyclodextrin derivatives on aceclofenac release from directly compressible tablets. Pharmazie (2007) 1.06
Sex education: to be or not to be. J Postgrad Med (1980) 1.06
Diagnostic lag period in kala-azar: test for early diagnosis needed. J Assoc Physicians India (1991) 1.06
A simple and sensitive test for field diagnosis of post kala-azar dermal leishmaniasis. Br J Dermatol (2001) 1.04
Anthropometrically derived dosing and drug costing calculations for treating visceral leishmaniasis in Bihar, India. Trop Med Int Health (2008) 1.02
Gas embolism death after laparoscopy delayed by "trapping" in portal circulation. Anesth Analg (1978) 1.02
Increased metacyclogenesis of antimony-resistant Leishmania donovani clinical lines. Parasitology (2011) 1.01
Best practice in primary care pathology: review 4. J Clin Pathol (2006) 1.00
Differential gene expression analysis in antimony-unresponsive Indian kala azar (visceral leishmaniasis) clinical isolates by DNA microarray. Parasitology (2007) 0.99
Expression of the VLDL receptor in endothelial cells. Arterioscler Thromb Vasc Biol (1996) 0.97
Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer. Br J Cancer (2011) 0.97
Information needs of Asian and White British cancer patients and their families in Leicestershire: a cross-sectional survey. Br J Cancer (2004) 0.97
Novel and frequent mutations of hepatitis B virus coincide with a major histocompatibility complex class I-restricted T-cell epitope of the surface antigen. J Virol (1997) 0.96
Management of visceral leishmaniasis: Indian perspective. J Postgrad Med (2005) 0.96
Miltefosine: issues to be addressed in the future. Trans R Soc Trop Med Hyg (2006) 0.94
Sodium stibogluconate resistance in Leishmania donovani correlates with greater tolerance to macrophage antileishmanial responses and trivalent antimony therapy. Parasitology (2005) 0.94
Evaluation of rK28 antigen for serodiagnosis of visceral Leishmaniasis in India. Clin Microbiol Infect (2011) 0.93
In search of an ideal test for diagnosis and prognosis of kala-azar. J Health Popul Nutr (2010) 0.93
Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991. Eur J Cancer (2009) 0.93
Therapeutic and cosmeceutical potential of ethosomes: An overview. J Adv Pharm Technol Res (2010) 0.92
Impact of neutropenia on delivering planned chemotherapy for solid tumours. Eur J Cancer Care (Engl) (2008) 0.92
Correlation between clinical features and degree of immunosuppression in HIV infected children. Indian Pediatr (2008) 0.91
Central venous catheters for out-patient management of malignant disorders. Arch Dis Child (1983) 0.91
Treatment of post-kala-azar dermal leishmaniasis. Int J Dermatol (1995) 0.90
Human visceral leishmaniasis is not associated with expansion or accumulation of Foxp3+ CD4 cells in blood or spleen. Parasite Immunol (2010) 0.89
Platinum-based chemotherapy in metastatic breast cancer: the Leicester (U.K.) experience. Clin Oncol (R Coll Radiol) (2005) 0.89
Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant recipients with gastrointestinal tract disorders. Transplant Proc (2008) 0.88
Alteration of Fas and Fas ligand expression during human visceral leishmaniasis. Clin Exp Immunol (2002) 0.88
Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani. Parasitology (2007) 0.87
Determinants of bednet ownership and use in visceral leishmaniasis-endemic areas of the Indian subcontinent. Trop Med Int Health (2009) 0.87
Re-induction of hormone sensitivity to diethylstilboestrol in androgen refractory prostate cancer patients following chemotherapy. Br J Cancer (2008) 0.87
The role of zinc and metallothionein in the dextran sulfate sodium-induced colitis mouse model. Dig Dis Sci (2007) 0.87
Human resource assessment for scaling up VL active case detection in Bangladesh, India and Nepal. Trop Med Int Health (2013) 0.86
Evaluating PET-CT in the detection and management of recurrent cervical cancer: systematic reviews of diagnostic accuracy and subjective elicitation. BJOG (2013) 0.86
A microculture technique for isolating live Leishmania parasites from peripheral blood of visceral leishmaniasis patients. Acta Trop (2007) 0.86
Porous carriers for controlled/modulated drug delivery. Indian J Pharm Sci (2009) 0.86
Buccoadhesive gels of glibenclamide: a means for achieving enhanced bioavailability. Drug Deliv (2009) 0.85
Development and performance evaluation of amphotericin B transfersomes against resistant and sensitive clinical isolates of visceral leishmaniasis. J Biomed Nanotechnol (2010) 0.84
Pediatric renal transplantation--Indian experience. Indian Pediatr (1998) 0.84
Digoxin toxicity and electrolytes: a correlative study. Acta Cardiol (1983) 0.84
Sentinel lymph node status in vulval cancer: systematic reviews of test accuracy and decision-analytic model-based economic evaluation. Health Technol Assess (2013) 0.84
Intermittent right bundle branch block due to digoxin toxicity--a rare electrocardiographic manifestation. Indian Heart J (1983) 0.84
Village health workers in Bihar, India: an untapped resource in the struggle against kala-azar. Trop Med Int Health (2012) 0.84
Low dose cyclosporine-a therapy in severe aplastic anaemia. J Assoc Physicians India (2001) 0.83
Efficacies of vesicular and free sodium stibogluconate formulations against clinical isolates of Leishmania donovani. Antimicrob Agents Chemother (2001) 0.83
Diagnostic and prognostic potential of a competitive enzyme-linked immunosorbent assay for leishmaniasis in India. Clin Diagn Lab Immunol (1999) 0.83
Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling. Health Technol Assess (2013) 0.83
Anti-66 kDa antileishmanial antibodies as specific immunodiagnostic probe for visceral leishmaniasis. Indian J Med Res (1994) 0.83
Management of multiple arteries in renal transplantation. Transplant Proc (1994) 0.82
Ketoconazole in visceral leishmaniasis. Lancet (1991) 0.82
Increased production of interleukin-1 and tumor necrosis factor by human monocytes treated in vitro with cisplatin or other biological response modifiers. Immunol Lett (1992) 0.81
Monitoring drug effectiveness in kala-azar in Bihar, India: cost and feasibility of periodic random surveys vs. a health service-based reporting system. Trop Med Int Health (2011) 0.81
Identification of antibodies directed against O-acetylated sialic acids in visceral leishmaniasis: its diagnostic and prognostic role. Glycoconj J (1998) 0.81
Role of yoga in management of essential hypertension. Acta Cardiol (1984) 0.81
Reactive oxygen intermediates, nitrite and IFN-gamma in Indian visceral leishmaniasis. Clin Exp Immunol (2001) 0.81
Sero-epidemiological study of kala-azar in a village of Varanasi district, India. Trop Med Int Health (2006) 0.80
Enhanced expression of Toll-like receptors 2 and 4, but not 9, in spleen tissue from patients with visceral leishmaniasis. Parasite Immunol (2014) 0.80
Failure of ketoconazole treatment in cutaneous leishmaniasis. Int J Dermatol (1995) 0.79
Topical antiinflammatory effects of Euphorbia prostrata on carrageenan-induced footpad oedema in mice. J Ethnopharmacol (1990) 0.79
Intrathecal morphine reduces breakthrough pain during labour epidural analgesia. Br J Anaesth (2007) 0.79
Molecular typing of HLA class I and class II antigens in Indian kala-azar patients. Trop Med Int Health (1997) 0.79
Evaluation of the status of tuberculosis as part of the clinical case definition of AIDS in India. Postgrad Med J (2005) 0.79
Platelet function studies in Indian kala-azar. J Trop Med Hyg (1995) 0.79
A case of paclitaxel-induced pancreatitis. Clin Oncol (R Coll Radiol) (2003) 0.79